Search

everythinglearnresearchcommunity

for

Search:↓

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

The reported treatment depths were likely incorrect and could risk patient safety.

Metal-organic frameworks can help heal wounds, reduce scars, and promote hair growth, but more research is needed.

Combining PRP, microneedling, and minoxidil may improve hair regrowth in severe hair loss cases.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Combining PRP with microneedling and minoxidil may help treat severe hair loss.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Biodegradable microneedle patches help topical steroids work better for prurigo nodularis.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Oral minoxidil may help with pediatric hair disorders but has notable side effects.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Alitretinoin may help treat alopecia areata.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Different parts of the body's fat tissue have unique cell types and characteristics, which could help treat chronic wounds.

Provenge extends prostate cancer survival by about 4 months.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Vimentin, desmin, and laminin help maintain rat skin structure.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Minoxidil lowers blood pressure without worsening lung pressure but can cause increased hair growth.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.